CannabisNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Posts Update on Washington State Assets

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning posted a shareholder update regarding its Washington State assets. Per the update, the company received an encouraging report from the general manager of its Washington state licensee partner that detailed increases from April of 30% in sales, 36% in crop yield and 100% in retail client stores. Chemistree also announced that Sugarleaf requested extra cultivation facilities at the Sedro Wooley location, on the same turn-key basis as currently in place, so it can double its current capacity and meet the quickly growing demand for Sugarleaf branded products. “These numbers are surpassing my expectations and I am really proud of the team at Sugarleaf for their focus on producing a high-quality cultivated product, an exacting attention to detail, and maintenance of rigid best practices in all parts of the operation. The Sugarleaf order book is now fully spoken for each month and the team now has new clients looking for Sugarleaf products every week. I know I speak for the entire Chemistree management team when I say how pleased we are to be landlords to such an amazing cultivator,” Chemistree chief cannabis officer Sheldon Aberman stated in the news release.

To view the full press release, visit http://cnw.fm/7XjXq

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. For more information, visit the company’s website at www.Chemistree.ca.

NOTE TO INVESTORS: The latest news and updates relating to CHMJF are available in the company’s newsroom at http://cnw.fm/CHM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – GP Solutions, Inc. (GWPD) Inks Deal with Snoop’s Premium Nutrients to Create Specialized Grow Pods, Become Nutrient Distributor

GP Solutions (OTC: GWPD), the developer of highly innovative automated micro-farms trade named “GrowPods,” on Monday announced that it has signed a deal to become a distributor of Snoop’s Premium Nutrients, a premier product line developed in Holland exclusively for the cannabis market. In addition, GP Solutions will produce a series of customized, co-branded GrowPods called “Snoop’s Premium Nutrients Pods”, which will come with a 6-month supply of the premium nutrients. The company will be premiering the first Snoop’s Premium Nutrients Pods at CannaCon South, taking place September 27-28 in Oklahoma City. “This is an enormous opportunity for our company that will heighten visibility in the cannabis market and give growers a complete solution for rapid and robust cultivation,” GP Solutions CEO George Natzic stated in the news release. “We are now positioned as the most complete turnkey system in the industry.”

To view the full press release, visit http://cnw.fm/g57Zg

About GrowPod

GrowPod, Inc. is the developer of highly innovative automated micro-farms trade named “GrowPods”. GrowPods are a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. Offering fully insulated, food-grade shipping container that has been specifically modified to provide the optimum controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. With the company’s combination of hydroponic and certified organic soil systems, clients can produce a significantly higher yield that grows faster, healthier and more consistent. For more information, visit the company’s website at www.GrowPodSolutions.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury

Traumatic brain injury is a condition that is more common than most people care to admit. Research estimates that two million-plus people visit the ER each year with cases related to TBI. These cases occur from events such as car accidents, falls and physical attacks, and they result in minor concussion or severe traumatic brain injury. Fifty percent of the TBI injuries are connected to falls by children between the ages of 1-14 years and old folks over the age of 60. The World Health Organization lists TBI among the leading causes of death in young children.

To understand how people with TBI can benefit from using marijuana, we must first understand what traumatic brain injury means. Traumatic Brain Injury is the damage to the brain which is attributed to an external force. TBI can lead to premature death or permanent disability. TBI, like concussion, is most evident among football players and war veterans. Individuals suffering from TBI display symptoms such as dizziness, headaches, nausea, speech difficulties, difficulties controlling their motor function, sensitivity to light, seizures and amnesia.

Research shows that 30 clinical trials have failed to provide much-needed treatment for TBI. However, none of these trials included the use of cannabis which when used, activates the innate cannabinoid receptors, which help in reducing swelling in the brain and improve neurological impairment. When cannabinoid 2-AG is administered into a damaged mice’s brain, its cognitive and motor function are seen to improve significantly. Marijuana can also be used to treat other physiological conditions such as insomnia.

Studies show that Traumatic Brain Injury can result in brain edema, neural impairment, increase in microglial cell number, activation and DAI (diffuse axonal injury). The damage to the brain escalates cellular permeability thus allowing water to enter the brain which causes edema. Edema formation in humans can cause one to forget minor things such as their shopping list while impulsive behaviour and spatial learning and memory issues are observed in animals. Edema formation accounts for about fifty percent mortality rate of TBI patients. To treat edema, scientists applied the use of cannabinoid receptors (CB1 and CB2) as they help in decreasing brain edema.

However, through research CB1 receptors are less involved in the treatment effect of this drug. Thus to ensure effectiveness, scientists indicate that both receptors should be used together to increase the chances of neuroprotective actions. The study was successful because the scientists were in a lab setting, and they had the advantage of administering the dosage immediately after the accident. The research on the use of CB receptors on mice was led by Raphael Mechoulam and a top team from Hebrew University.

In the world of athletics, where the use of drugs is prohibited, it would be criminal to deny the administration of medical marijuana if a doctor determines that a single dose be administered immediately after concussion.

Experts are convinced that it is these types of findings that encourage cannabis companies like Marijuana Company of America Inc. (OTCQB: MCOAD) and MustGrow Biologics Corp. (CSE: MGRO) to keep working and making better products so that more people can benefit from what marijuana has to offer.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Medical Marijuana Legalization Bill Introduced in Wisconsin

Three legislators in Wisconsin have united to introduce a bill legalizing the use of marijuana for medicinal purposes. The legislators include two Democrats, Erpenbach and Taylor, and Testin who is a Republican.

Sen. Jon Erpenbach, Taylor and Testin in a joint statement on Friday announced that the time has come for the state of Wisconsin to lift the restrictions and legalize the use of marijuana. The bill would create a system that allows patients to be entered into a list through registration and the growers to be issued with a license permitting them to grow cannabis for medical purposes.

In the United States, there are 33 states legally using marijuana either for medical or recreational purposes. Among these are, Michigan and Minnesota. In Colorado and nearly a dozen other states, residents can use marijuana for medical and recreational purposes.

In the statement, Testin said that the government should not decide if marijuana is right for inducing treatment; doctors and patients should be given that mandate to determine if cannabis is right for treating a particular condition.

For the past decade, the Democrats have been trying to pass marijuana legalization bills with no success. However, it is still uncertain whether with the Republican support exemplified by Testin, the bill will be passed into law. Speaker of the Assembly, Robin Vos is open to passing the bill but the Senate Majority Leader, Scott Fitzgerald has openly voiced his opposition.

Tony Evers, the Democratic governor, had proposed legalization of medical marijuana, in the Winsconsin budget, but the provisions were not included in the final budget plan.

Through his spokesman, the governor did not comment on the bill. Moreover, since he is running for Congress in the year 2020 in a Wisconsin district that is traditionally conservative, his stand on the bill is unlikely to change. Supporting the bill would pose a threat for him as it would be a motivating factor for his primary challengers.

The proposed marijuana legalisation bill has the following terms that have to be met by the doctors, patients and the cannabis growers.

Persons qualifying to receive medical marijuana have to be suffering from one of the following ailments; AIDS, cancer, Alzheimer’s, PTSD (post-traumatic stress disorder), traumatic brain injury (TBI), and severe and chronic pain.

Before being registered and joining the list of people to receive medical marijuana treatment, a doctor should diagnose the patient, explain the risk factors as well as the benefits of using medical marijuana.

Patients applying to receive medical marijuana are supposed to pay $250 for registration and $250 in annual fees.

The marijuana registry is not visible to the public and people who are or have been convicted of a drug-related crime are not allowed to join the list.

The Department of Agriculture, Trade and Consumer Protection would set up a licensing system for the growers, if the bill remains as it is. The licensed growers would include persons growing a dozen-plus marijuana plants. Grower would have to pay an initial fee of $250 and an annual fee of $5000. The licensed growers would also be prohibited from growing cannabis for family or personal consumption.

On Friday, Evers tweeted his supports for the bill while pointing to a recent poll by the Marquette University Law School which showed that 83 percent supported the legalization of medical marijuana. In the tweet he wrote that now was the time for physicians to be allowe to prescribe the medication that they felt was best placed to treat their patients.

Analysts believe that the chances of this bill sailing through are too close to call, and they also believe that industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) would wish that patients have the option of using medical marijuana sooner rather than later.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Marijuana Banking Bill Changes Suggested to Win Republican Support

On Monday, we reported that Congress was likely to vote on the SAFE Banking Act this month, and the latest indicators strongly point to a floor vote being scheduled for next week. The supporters of the bill would like the vote to be conducted under suspended House rules, and a number of amendments have been suggested to win over more Republicans and ensure that the bill will get the two-thirds majority needed under the suspended rules arrangement.

One of the changes that has been made provides clarification that the protections given to banks that work with state-legal marijuana companies also apply to the banks serving companies in the hemp and CBD industries.

Another change expands the definition of the ancillary businesses that work with marijuana companies. The expanded definition includes insurance companies and federal home loan companies. The bill also states that financial regulators wouldn’t have any undue restrictions placed upon them as they supervise marijuana companies.

An extra section added to the SAFE Banking Act also talks extensively about the hemp industry and why financial regulators must release guidelines explaining how banking institutions can work with the hemp and CBD industries without facing any sanctions from regulators.

There is also a specific section that is aimed at forestalling any plan by the Justice Department to arbitrarily order banks to close the account or accounts of a company or people in the firearms industry as a way of forcing those entities out of business. Any such action must be accompanied by a sound reason.

All these provisions are aimed at putting the concerns of conservative lawmakers at bay, especially those who don’t want to be involved in passing a law that is primarily intended to facilitate the marijuana industry. By including the hemp, CBD and gun industries, the scope of the bill is expanded and more GOP lawmakers may be enticed to support it.

However, not all is well within the Democratic caucus as some members have been vocal that they will not support the bill unless measures to address social equity issues in the marijuana industry are first implemented.

Such members of Congress feel that the SAFE Banking Act largely helps banks and marijuana companies to thrive and yet a more pressing concern are the racial issues surrounding the implementation of marijuana laws across the country.

Supporters of the proposed law say that any measure that chips away at prohibition should be supported and the social equity issues will also be addressed by the other bills before different committees of the House of Representatives.

Analysts believe marijuana sector players like Hemptown USA and HTC Extraction Systems (TSX.V: HTC) will be waiting keenly to hear what comes out of Congress when the bill is voted on.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New Hampshire Assembly Overrides Veto on Marijuana Home Grows

The House of Representatives in New Hampshire voted on Wednesday to override Gov. Sununu’s veto of a bill that seeks to allow registered medical marijuana patients to grow a limited number of marijuana plants at home for their medical needs.

In the message that the governor wrote to explain his veto, Sununu said that allowing home cultivation would make it very hard for law enforcement to prevent marijuana from registered medical users finding its way onto the marijuana black market.

The House didn’t agree with his reasoning and they voted 259 to 120 to overturn the veto on House Bill 364. This measure now heads to the state Senate where it had earlier passed with a slim majority of 14 to 10.

Under current state law, it is illegal to grow medical marijuana at home even if one is a registered patient or caregiver. HB 364 wants to change this position and allow patients or their caregivers to have three mature cannabis plants, three immature ones, and a maximum of 12 seedlings.

Activists are calling on the state Senate to follow the lead of the House and vote to override the governor’s veto. These activists argue that it is currently very hard for many patients to travel long distances in order to buy the needed medical marijuana products from one of the only four licensed dispensaries.

To compound matters even further, the limited number of dispensaries means that the medical marijuana products available are more expensive than they would have been if there were more players in the sector competing against each other.

The activists therefore see home grows as an opportunity for patients to access the treatment that they need without facing financial ruin due to the high cost of manufactured medical marijuana products.

Two recent polls in the state revealed that nearly 70 percent of the residents support the legalization of medical marijuana. Furthermore, the three states neighboring New Hampshire have all allowed medical marijuana patients to grow a limited number of plants for their own use.

All eyes are therefore going to be on the senators and how they vote once this measure returns to the upper chamber of the state legislature. If all who voted for the bill earlier remain supporting the measure, then the proponents of the bill will have to convince at least two of the ten senators who voted against the bill to change their position and support it.

Without two-thirds of the Senate voting to override the veto, then the decision of the governor will stand and the status quo will remain for the 7,000 medical marijuana patients on the state program.

It is widely believed that the entire industry, including companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Green Hygienics Holdings Inc. (OTCQB: GRYN) will be following the developments around this bill closely.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Demonstrates Growth with Encouraging Financial Results

Geyser Brands (TSX.V: GYSR) recently reported notable financial results for the eight months ended March 31, 2019 (http://cnw.fm/4Wa6M). An article discussing the company reads, “‘We are pleased with our progress in the first eight months since completing the RTO. Our subsidiary, 0957203 B.C. Ltd. dba Apothecary Botanicals, through its strong management, has been successful in bringing its facility to GMP-compliant standards for manufacturing and processing and in obtaining Health Canada licensing for Cultivation and Standard Processing,’ Geyser CEO Andreas Thatcher said in a news release. . . . The financial report features a couple of important highlights that stand as evidence of Geyser’s growth. As of March 2019, the company’s total assets reached $4,890,422, in comparison to $4,504,411 as of July 31, 2018. Total shareholders’ equity reached $3,843,153 (from $3,405,399 in July 2018).”

To view the full article, visit http://cnw.fm/0MMSi

About Geyser Brands Inc.

Geyser Brand builds health-based, hemp-CBD consumer products in the nutraceutical, cosmetics, food & beverage and pet sectors worldwide. Geyser Brands owns a Health Canada-approved Licensed Producer (“LP”) in Port Coquitlam, British Columbia, that holds cultivation and processing licenses. The company is also anticipating its R&D and sales licenses. Geyser Brands will utilize its GMP-licensed facilities in British Columbia for the manufacturing and international distribution of its hemp and CBD-based products. For more information, visit the company’s website at www.GeyserBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

HempNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Hemp Cigarette Product on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is syndicated internationally and covers money-focused topics, featuring various companies and in-depth CEO and executive interviews that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. This week’s program featured SinglePoint CEO Greg Lambrecht as he discussed the company’s hemp cigarette product.

To view the full press release, visit http://cnw.fm/uflS6

About SinglePoint, Inc.

SinglePoint, Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

CannabisNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Announces Pricing of $7.25M Underwritten Public Offering

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, on Thursday announced the pricing of its underwritten public offering of 290,000 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock, each at price of $25.00. The company expects to receive approximately $7,250,000 in gross proceeds from the offering, with the closing, subject to the satisfaction of customary conditions, expected to occur on or about September 24, 2019. The shares are expected to be traded under the symbol “YGYIP” on Nasdaq and will not be convertible into or exchangeable for any of the company’s other securities.

To view the full press release, visit http://cnw.fm/nRQ5c

About Youngevity International Inc.

Youngevity International Inc. is a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a commercial hemp enterprise and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity; YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) Completes SolDaze Acquisition

TransCanna Holdings (CSE: TCAN) (FRA: TH8) on Thursday announced that it has closed the acquisition of all the outstanding equity interest in Tres Ojos Naturals LLC, currently doing business as SolDaze. TransCanna paid a purchase price comprised of a cash payment of $200,000 (including a previously paid deposit of $50,000) and the issuance of 810,000 common shares at a deemed price of $1.14 each. Another cash payment of $150,000 will be paid on November 15, 2019 to satisfy the remaining cash portion of the purchase price. TCAN and the vendors entered into a voluntary pooling agreement concerning the closing share consideration, which details the release of the shares over a two-year period, subject to an increase in speed if the sales of SolDaze products reach predetermined revenue targets. The number of shares released may also be lowered if certain revenue targets are not met by the dates specified.

To view the full press release, visit http://cnw.fm/64MXi

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://cnw.fm/TCAN

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com